- 期刊
Drug-Eluting Stents versus Bare-Metal Stents in Taiwanese Patients with Acute Coronary Syndrome: An Outcome Report of a Multicenter Registry
並列摘要
Background: The study aims to compare cardiovascular outcomes of using bare-metal stents (BMS) and drugeluting stents (DES) in patients with acute coronary syndrome (ACS) through analysis of the database from the Taiwan ACS registry. Large domestic studies comparing outcomes of interventional strategies using DES and BMS in a Taiwanese population with ACS are limited. Methods and Results: Collected data regarding characteristics and cardiovascular outcomes from the registry database were compared between the BMS and DES groups. A Cox regression model was used in an unadjusted or adjusted manner for analysis. Baseline characteristics apparently varied between DES group (n=650) and BMS group (n=1672) such as ACS types, Killip's classifications, or coronary blood flows. Compared with the BMS group, the DES group was associated with significantly lower cumulative incidence of all-cause mortality (3.4% vs. 5.8%, P=0.008), target vessel revascularization (TVR) (5.2% vs. 7.4%, p=0.035), or major adverse cardiac events (MACE) (10.2% vs. 15.6%, P＜0.001) at 1 year in a real-world setting. Cox regression analysis showed the BMS group referenced as the DES group had significantly higher risk-adjusted total mortality [hazard ratio (HR)=1.85, P=0.026], target vessel revascularization (TVR) (HR=1.59, P=0.035), and MACE (HR=1.68, P=0.001). Conclusions: The data show use of DES over BMS provided advantages to patients with ACS in terms of lower l-year mortality, TVR, and MACE. The study suggests implantation of DES compared with BMS in Taiwanese patients with ACS is safe and beneficial in the real-world setting.
延伸閱讀
- Sung, S. H., Chen, T. C., Cheng, H. M., Lee, J. C., Lang, H. C., & Chen, C. H. (2017). Comparison of Clinical Outcomes in Patients Undergoing Coronary Intervention with Drug-Eluting Stents or Bare-Metal Stents: A Nationwide Population Study. Acta Cardiologica Sinica, 33(1), 10-19. https://doi.org/10.6515/ACS20160608A
- Lai, C. C., & Mar, G. Y. (2016). Author Reply to Letter to the Editor: Drug-Eluting Stents versus Bare-Metal Stents in Taiwanese Patients with Acute Coronary Syndrome: An Outcome Report of a Multicenter Registry. Acta Cardiologica Sinica, 32(1), 121-122. https://doi.org/10.6515/ACS20150504B
- Tsai, M. L., Hsieh, M. J., Chen, C. C., Chang, S. H., Wang, C. Y., Chen, D. Y., Yang, C. H., Yeh, J. K., Ho, M. Y., & Hsieh, I. C. (2020). Comparison of 9-Month Angiographic Follow-Up and Long-Term Clinical Outcomes of Biodegradable Polymer Drug-Eluting Stents and Second-Generation Durable Polymer Drug-Eluting Stents in Patients Undergoing Single Coronary Artery Stenting. Acta Cardiologica Sinica, 36(2), 97-104. https://doi.org/10.6515/ACS.202003_36(2).20190729A
- Panchal, K., Patel, S., & Bhatt, P. (2012). Drug-Eluting Stents in Multivessel Coronary Artery Disease: Cost Effectiveness and Clinical Outcomes. Advances in Pharmacological Sciences, 2012(), 162-167. https://doi.org/10.1155/2012/679013
- Liu, C. C., Wang, J. Y., Yen, I. P., & Lai, C. J. (2011). One-Year Follow-Up after Percutaneous Coronary Intervention with Titanium-Nitride-Oxide-Coated Stents Versus Paclitaxel-Eluting Stents in Patients from Real-World Clinical Practice. Acta Cardiologica Sinica, 27(2), 94-100. https://www.airitilibrary.com/Article/Detail?DocID=10116842-201106-201107070022-201107070022-94-100